Leftover Embryonic Cells Connect Gastric Reflux And Cancer
6/24/2011
The ultimate source of some cancers is embryonic cells. Research published in the June 24th Cell, a Cell Press publication, traces the precursor of deadly esophageal cancers to leftover embryonic cells found in all adults. Some people with gastric reflux disease have a greater risk of developing esophageal cancer...
Researchers Suggest New Way Of Looking At What Causes Sepsis
6/24/2011
Researchers at St. Michael's Hospital have put forward a new theory as to what causes sepsis, an often fatal condition that occurs when infection spreads throughout the body. Leaking blood vessels may actually be a cause of sepsis, rather than a symptom as previously thought, said Dr. Warren Lee...
BUSM Study Identifies New Potential Approach To Treat Myelofibrosis
6/24/2011
A new study conducted by a team of researchers at Boston University School of Medicine (BUSM) sheds light on a possible new approach to treat the bone marrow disease known as myelofibrosis by inhibiting an enzyme that connects extracellular fibers...
Current Treatments For Chronic Pain Do Not Generally Eliminate Pain Or Restore Function
6/24/2011
The majority of patients with chronic pain do not get proper pain relief or the restoration of function from their current treatment, researchers from the University of Washington, Seattle, revealed in the journal The Lancet today. This article is part of a second The Lancet Series on pain...
European Medicines Agency Concludes Review Of Systemic Nimesulide-containing Medicines
6/23/2011
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefits of systemic nimesulide-containing medicines continue to outweigh their risks in the treatment of patients with acute pain and primary dysmenorrhoea. However, these medicines should no longer be used for the symptomatic treatment of osteoarthritis...
Clavis Pharma ASA (OSE: CLAVIS), the Norwegian cancer drug development company, announces that Clovis Oncology, Inc, its development partner for CP-4126, has expanded the ongoing observational study to determine the patient stratification parameters in the pivotal LEAP clinical trial with CP-4126...
Patient Partnership: A Powerful Shift In Health Care Delivery At UAMS Myeloma Institute
6/23/2011
A new model of care developed for patients at the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences (UAMS) has led to improved patient experience, lower costs and better patient outcomes. The model of care featured recently in an online article in the Journal of Participatory Medicine, was developed by Elias Anaissie, M.D...
Hereditary Colon Cancer Syndrome Marked By Abnormally Dense Blood Vessel Growth In Mouth
6/23/2011
A team led by Johns Hopkins researchers has found that a hereditary colon cancer syndrome, familial adenomatous polyposis (FAP), is associated with abnormally dense blood vessel growth in the skin lining the mouth...
The European Medicines Agency is currently reviewing results from pharmacoepidemiological studies, non-clinical and clinical data and post-marketing reports on pioglitazone-containing medicines and the occurrence of bladder cancer, to assess their impact on the balance of benefits and risks of these medicines...
20% Of Breast Implants Removed Within 10 Years
6/23/2011
Women who have breast implants need to know that the risk of complications and having them removed or replaced grows with time, the FDA (Food and Drug Administration) announced. 20% of women who received breast augmentation implants will have to have them removed within 10 years of the procedure. For breast reconstruction the figure could be as high as 1 in every 2 within ten years...